ASSAY FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE BASED ON THE DETERMINATION OF THE RATIO OF hABeta42:hABeta40

Details for Australian Patent Application No. 2003236714 (hide)

Owner THE GENETICS COMPANY, INC.

Inventors HARTMANN, Tobias; EIKENBERG, Oliver; ANTZ, Christof

Pub. Number AU-A-2003236714

PCT Number PCT/EP03/05982

PCT Pub. Number WO2003/104812

Priority 02012583.7 06.06.02 EP

Filing date 6 June 2003

Wipo publication date 22 December 2003

International Classifications

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 02012583.7 06.06.02 EP

19 February 2004 Application Open to Public Inspection

  Published as AU-A-2003236714

24 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003236715-USE OF ORALLY-AVAILABLE PROSTACYCLIN DERIVATIVES FOR THE PRODUCTION OF A MEDICAMENT FOR THE TREATMENT OF DISEASE STATES ASSOCIATED WITH BONE MARROW OEDEMA

2003236713-STABLE OIL IN WATER EMULSION